Filing Details
- Accession Number:
- 0001209191-16-127051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-10 16:08:31
- Reporting Period:
- 2016-06-09
- Filing Date:
- 2016-06-10
- Accepted Time:
- 2016-06-10 16:08:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 819050 | Vical Inc | VICL | Biological Products, (No Disgnostic Substances) (2836) | 930948554 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1198238 | B Vijay Samant | 10390 Pacific Center Court San Diego CA 92121 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 Par Value | Acquisiton | 2016-06-09 | 15,700 | $4.72 | 112,632 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents a weighted average purchase price per share. The prices actually paid ranged from $4.65 to $4.78. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- Such number reflects the 1-for-10 reverse stock split of the issuer's common stock on May 26, 2016, resulting in the Reporting Person's ownership of 872,394 fewer shares of common stock.
Billionaire Hedge Funds
